Race, ethnicity, and clinical outcomes in hormone receptor-positive, human epidermal growth factor 2 negative (HER2-), node negative breast cancer in the randomized TAILORx trial: gaps in biologic and social determinants of health.

Ann Transl Med

Division of Medical Oncology, Department of Medicine, The Ottawa Hospital Cancer Centre and the University of Ottawa, Ottawa, ON, Canada.

Published: December 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843404	PMC
http://dx.doi.org/10.21037/atm-2022-59	DOI Listing

Publication Analysis

race ethnicity

ethnicity clinical

clinical outcomes

outcomes hormone

hormone receptor-positive

receptor-positive human

human epidermal

epidermal growth

growth factor

factor negative

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!